Health Canada is facing increased criticism for its approval of generic oxycodone after the US Food and Drug Administration (FDA) decided to ban generic versions of the drug that has been widely abused across North America. The FDA made its landmark ruling just days before Purdue Pharma’s patent on the original time-release formula of OxyContin was set to expire Apr. 23.
Health Canada has updated the labeling for commonly prescribed cholesterol-lowering drugs called statins to warn users they may be at a small increased risk of developing diabetes. The department announced the change on Thursday; 11 months after the U.S. Food and Drug Administration took similar action.
January 24, 2013 | The Globe and Mail | News Article
People who take everyday doses of painkillers have a 20-to-40-per-cent greater risk of crashing their cars, a Canadian study shows. While that is a significantly lesser risk than driving while impaired by alcohol, patients and prescribers alike should be aware of the potential impact of opioid-based pain medication on their safety, researchers say.
Study first to show driving risk tied to use of drugs like morphine in real world.